NEW SAUDI ARABIAN CARRIER RIYADH AIR TO LAUNCH WITH ALL-BOEING FLEET OF UP TO 72 787-9 DREAMLINERS

Boeing [NYSE: BA] and Riyadh Air announced today that the new Saudi Arabian carrier has chosen the 787 Dreamliner to power its global launch and support its goal of operating one of the most efficient and sustainable fleets in the world.

Boeing and Riyadh Air announced today that the new Saudi Arabian carrier has chosen the 787 Dreamliner to power its global launch and support its goal of operating one of the most efficient and sustainable fleets in the world.

Owned by Saudi Arabia’s Public Investment Fund (PIF), Riyadh Air said it will purchase 39 highly efficient 7879s, with options for an additional 33 787-9s. Based in the capital city, Riyadh Air will play a key role in growing Saudi Arabia’s air transport network.

This agreement is part of Saudi Arabia’s wider strategic plan to transform the country into a global aviation hub. In total, Saudi Arabian carriers today announced their intent to purchase up to 121 787 Dreamliners in what will be the fifth largest commercial order by value in Boeing’s history. This will support the country’s goal of serving 330 million passengers and attracting 100 million visitors annually by 2030.

“The new airline reflects the ambitious vision of Saudi Arabia to be at the core of shaping the future of global air travel and be a true disrupter in terms of customer experience,” said Tony Douglas, CEO of Riyadh Air.

“Riyadh Air’s commitment to its customers will see the integration of digital innovation and authentic Saudi hospitality to deliver a seamless travel experience. By positioning the airline as both a global connector and a vehicle to drive tourist and business travel to Saudi Arabia, our new 787-9 airplanes will serve as a foundation for our worldwide operations, as we build the wider network and connect our guests to Saudi Arabia and many destinations around the world,” Douglas said.

“This is a significant order that will support Riyadh Air’s commitment to deliver a world-class travel experience, while supporting American aerospace manufacturing jobs at Boeing and across our supply chain,” said Stan Deal, president and CEO of Boeing Commercial Airplanes. “We are incredibly proud of our nearly eight decades of partnership to drive innovation and sustainable growth in Saudi Arabia’s aviation sector. Our agreement builds on that longstanding partnership and will further expand access to safe and sustainable commercial air travel for decades more.”

The 787-9 provides the longest range of the 787 family of airplanes, flying approximately 300 passengers 7,565 nautical miles (14,010 km), with additional cargo capacity. Passengers enjoy a better experience with the largest windows of any jet, air that is more humid and pressurized at a lower cabin altitude for greater comfort, large overhead bins with room for everyone’s bag; soothing LED lighting, and technology that senses and counters turbulence for a smoother ride.

The 787 family is delivering unmatched fuel efficiency to airline operators around the world reducing fuel use and emissions by 25% compared to airplanes they replace.

This new order will be posted to Boeing’s Orders and Deliveries website once it is finalized.

As a leading global aerospace company, Boeing develops, manufactures and services commercial airplanes, defense products and space systems for customers in more than 150 countries. As a top U.S. exporter, the company leverages the talents of a global supplier base to advance economic opportunity, sustainability and community impact. Boeing’s diverse team is committed to innovating for the future, leading with sustainability, and cultivating a culture based on the company’s core values of safety, quality and integrity. Join our team and find your purpose at boeing.com/careers.

LA ROCHE-POSAY AND KING FAISAL SPECIALIST

LA ROCHE-POSAY AND KING FAISAL SPECIALIST

HOSPITAL FOUNDATION “WAREEF CHARITY”

JOIN FORCES TO ENHANCE DERMATOLOGICAL CARE

HOSPITAL FOUNDATION “WAREEF CHARITY” JOIN FORCES TO ENHANCE DERMATOLOGICAL CARE

Pioneering partnership focuses on advancing dermatological support and education for more than a thousand chemotherapy patients in Saudi Arabia

In a pivotal step towards elevating dermatological care in the region, La Roche-Posay, a global leader in skincare, has signed a Memorandum of Understanding (MOU) with King Faisal Specialist Hospital Foundation “Wareef Charity”. The partnership falls under the umbrella of La Roche-Posay’s internationally renowned ‘Fight with Care’ program, which has a decade-long record of furthering cancer supportive care.

In line with L’Oréal Dermatological Beauty’s commitment to the progressive development and robust support of the skincare and haircare sectors, this initiative sets a precedent in enriching patient experiences, and enabling them to access invaluable information related to skin and hair care preservation across various stages of their life.

The partnership is designed to strengthen and expand the support for patients undergoing chemotherapy at the King Faisal Specialist Hospital, offering them comprehensive training on the beneficial impact of dermo-cosmetics in alleviating treatment side effects. Throughout 2023, La Roche-Posay will provide specialized training to between 1,000 - 1,300 patients and donate thousands of units of its clinically proven skincare products, including Lipikar Baume AP+M and Cicaplast Baume B5.

Commenting on this partnership, Mohamed El Araby, General Manager L’Oreal Dermatological Beauty Division, Middle East. t, said: “This marks an important stride in our overarching commitment to enhance the skincare sector in the region. This forward-thinking partnership is an extension of our commitment to provide world class training, support and products to dermatologists and patients. A first-of-its-kind in the region under our ‘Fight with Care’ program, will see us combining forces to empower and educate patients about the transformative role of dermo-cosmetics in their wellbeing journey.”

Remi Naser, Brand Director La Roche-Posay said: “We are thrilled to be joining forces with King Faisal Hospital Foundation Wareef Charity under our longstanding “Fight with Care” program. 80% of cancer patients experience skin side effects, often leading to treatment interruptions. As such, we wanted to play a role in mitigating these effects by leveraging our decade-long expertise in skincare and oncology, to educate patients on the transformative role of dermo-cosmetics in their wellbeing journey. As part of this collaboration, La Roche-Posay will be supporting over 1,000 patients with dedicated skincare solutions as well as equip healthcare professionals with extensive training sessions. As we embark on this journey with King Faisal Hospital Foundation Wareef Charity, we look forward to harnessing the power of collaboration to improve patients’ lives during chemotherapy, to further allow them to navigate their treatment with enhanced comfort and confidence.”

Mr. Anwar Alsaqabi, Chief Executive Officer at “Wareef Charity” said: “With God’s grace and success, we have signed a partnership agreement with the “L’Oréal” company to provide the company’s products to oncology and cancer patients to mitigate the effects of their treatments and to help them make their daily lives better. The provision of ”L’Oréal” products to the patients of King Faisal Specialist Hospital and Research Center, which is one of the largest and most reliable medical edifices in the Middle East, is highly appreciated. We express our deepest thanks for this community contribution, which indicates a close and great cooperation. And we are all confident in its success and sustainability, God willing.”

This inaugural regional partnership under the ‘Fight with Care’ initiative underscores La Roche-Posay’s dedication to dermatology and paves the way for transformative patient support and care within the region.